What is the recommended antibiotic treatment for acute uncomplicated sinusitis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 10, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Antibiotic Treatment for Acute Uncomplicated Sinusitis

For acute uncomplicated bacterial sinusitis in adults, amoxicillin-clavulanate 875 mg/125 mg twice daily for 5-10 days is the preferred first-line antibiotic, with plain amoxicillin 500-875 mg twice daily reserved for patients without recent antibiotic exposure or risk factors for resistant organisms. 1, 2

When to Prescribe Antibiotics (Not All Sinusitis Needs Treatment)

Before prescribing any antibiotic, confirm the diagnosis meets one of three criteria for bacterial sinusitis:

  • Persistent symptoms ≥10 days without improvement (nasal congestion, purulent discharge, facial pain) 1, 2
  • Severe symptoms for ≥3 consecutive days: fever ≥39°C with purulent nasal discharge 1, 3
  • "Double sickening": worsening symptoms after initial improvement from a viral upper respiratory infection 1, 2

Critical pitfall: 98-99.5% of acute rhinosinusitis is viral and resolves spontaneously within 7-10 days without antibiotics. 1 Do not prescribe antibiotics for symptoms lasting <10 days unless severe symptoms are present. 1

First-Line Antibiotic Selection

Standard First-Line: Amoxicillin-Clavulanate

Amoxicillin-clavulanate 875 mg/125 mg twice daily for 5-10 days is preferred over plain amoxicillin because 50% of Haemophilus influenzae and 90-100% of Moraxella catarrhalis produce β-lactamase, rendering plain amoxicillin ineffective against these organisms. 4, 1, 2

When Plain Amoxicillin Is Acceptable

Plain amoxicillin 500 mg twice daily (mild disease) or 875 mg twice daily (moderate disease) remains acceptable for:

  • Uncomplicated cases without recent antibiotic exposure (within past 4-6 weeks) 1, 2
  • Patients without risk factors for resistant organisms 1

High-Dose Regimen for Resistant Organisms

Use high-dose amoxicillin-clavulanate (2 g amoxicillin/125 mg clavulanate twice daily) for patients with: 1, 2

  • Recent antibiotic use within past month
  • Age >65 years
  • Moderate-to-severe symptoms
  • Comorbid conditions or immunocompromised state
  • High local prevalence of penicillin-resistant Streptococcus pneumoniae (25-50% of strains) 4

Treatment Duration

Standard duration is 5-10 days, with most guidelines recommending treatment until symptom-free for 7 days (typically 10-14 days total). 1, 2 Shorter 5-7 day courses have comparable efficacy with fewer side effects. 1, 5

Reassess at 3-5 days: If no improvement, switch antibiotics or re-evaluate the diagnosis. 1, 2

Penicillin-Allergic Patients

Non-Severe Allergy (Rash, Delayed Reactions)

Second-generation cephalosporins are first-line alternatives: 1, 2

  • Cefuroxime-axetil 250-500 mg twice daily for 10 days

Third-generation cephalosporins provide superior activity against H. influenzae: 1, 2

  • Cefpodoxime-proxetil 200-400 mg twice daily for 10 days
  • Cefdinir 300 mg twice daily for 10 days

The risk of cross-reactivity between penicillins and second/third-generation cephalosporins is negligible (<1%). 1

Severe Allergy (Anaphylaxis/Type I Hypersensitivity)

Respiratory fluoroquinolones are the treatment of choice: 1, 6

  • Levofloxacin 500 mg once daily for 10-14 days 1, 7
  • Moxifloxacin 400 mg once daily for 10 days 1

These provide 90-92% predicted clinical efficacy against drug-resistant S. pneumoniae and β-lactamase-producing organisms. 1, 7

Critical pitfall: Do NOT use azithromycin or other macrolides—resistance rates exceed 20-25% for both S. pneumoniae and H. influenzae. 1 Do NOT use trimethoprim-sulfamethoxazole—50% resistance for S. pneumoniae. 1

Second-Line Treatment for Treatment Failure

If no improvement after 3-5 days of first-line therapy, switch to: 1, 2

High-dose amoxicillin-clavulanate (if not already used): 2 g amoxicillin/125 mg clavulanate twice daily for 10-14 days 1

OR

Respiratory fluoroquinolones: 1, 6

  • Levofloxacin 500 mg once daily for 10-14 days
  • Moxifloxacin 400 mg once daily for 10 days

Reserve fluoroquinolones for treatment failures, severe penicillin allergy, or complicated sinusitis (frontal, ethmoidal, sphenoidal involvement) to prevent resistance development. 1, 6

Adjunctive Therapies to Enhance Outcomes

Intranasal corticosteroids (mometasone, fluticasone, or budesonide twice daily) are strongly recommended as adjuncts to antibiotics—they reduce mucosal inflammation and improve symptom resolution. 1, 2

Short-term oral corticosteroids (typically 5 days) may be considered for: 1

  • Patients with marked mucosal edema
  • Failure to respond to initial antibiotic treatment
  • Acute hyperalgic sinusitis (severe facial pain)

Supportive measures: 1

  • Analgesics (acetaminophen, NSAIDs) for pain relief
  • Saline nasal irrigation for symptomatic relief
  • Adequate hydration
  • Sleeping with head elevated

Watchful Waiting Option

For adults with uncomplicated acute bacterial sinusitis, watchful waiting without immediate antibiotics is appropriate when reliable follow-up can be assured. 1, 2 Instruct patients to start antibiotics only if no improvement by 7 days or if symptoms worsen at any time. 1

The number needed to treat with antibiotics is 10-15 to achieve one additional clinical cure, as 90% of patients improve naturally within 7-15 days. 1

Pediatric Dosing Considerations

Standard-dose amoxicillin: 45 mg/kg/day divided into 2 doses 1

High-dose amoxicillin: 80-90 mg/kg/day divided into 2 doses for: 1

  • Age <2 years
  • Daycare attendance
  • Recent antibiotic use (within 4-6 weeks)
  • High local prevalence of resistant S. pneumoniae

High-dose amoxicillin-clavulanate: 80-90 mg/kg/day of amoxicillin component with 6.4 mg/kg/day clavulanate in 2 divided doses 1

For penicillin-allergic children: Cefpodoxime-proxetil 8 mg/kg/day in 2 doses 1

Reassess pediatric patients at 72 hours—if no improvement, switch to high-dose amoxicillin-clavulanate or consider complications. 1

When to Refer to a Specialist

Refer to otolaryngology or allergy/immunology for: 1

  • Symptoms refractory to two courses of appropriate antibiotics
  • Recurrent sinusitis (≥3 episodes per year)
  • Suspected complications (orbital cellulitis, meningitis, brain abscess)
  • Need for sinus aspiration/culture in immunocompromised patients
  • Evaluation for underlying allergic rhinitis, immunodeficiency, or anatomic abnormalities

Critical Pitfalls to Avoid

  • Never use first-generation cephalosporins (cephalexin, cefadroxil)—they have inadequate coverage against H. influenzae. 4, 1
  • Never use ciprofloxacin—it has poor activity against S. pneumoniae (AUC:MIC ratio only 10-20 vs. target of 25-30). 6
  • Never use clindamycin as monotherapy—it lacks activity against H. influenzae and M. catarrhalis. 1
  • Never use doxycycline as first-line—it has 20-25% predicted bacteriologic failure rate and limited activity against H. influenzae. 1
  • Do not continue ineffective therapy beyond 3-5 days—reassess and switch antibiotics if no improvement. 1, 2
  • Do not use topical decongestants >3 days—risk of rhinitis medicamentosa. 2
  • Complete the full antibiotic course even after symptoms improve to prevent relapse. 1

References

Guideline

Treatment of Acute Bacterial Sinusitis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Acute Bacterial Sinusitis Treatment Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Beginning antibiotics for acute rhinosinusitis and choosing the right treatment.

Clinical reviews in allergy & immunology, 2006

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Ciprofloxacin is Not Appropriate for First-Line Treatment of Sinus Infections

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.